Stabilized formulations containing Anti-interleukin-4 receptor (il-4r) antibodies
ME03135BActive Publication Date: 2019-04-20REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- ME2018276
- Authority / Receiving Office
- ME · ME
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2011-10-05
- Filing Date
- 2011-10-05
- Publication Date
- 2019-04-20
- Estimated Expiration
- 2031-10-05
Need to check novelty before this filing date? Find Prior Art
No text content released.